- Home
- PCRX vs PENG Comparison
PCRX vs PENG Comparison
Compare PCRX & PENG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PCRX | PENG |
|---|---|---|
| Founded | 2006 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 1.1B |
| IPO Year | 2011 | 2017 |
Fundamental Metrics
Financial Performance| Metric | PCRX | PENG |
|---|---|---|
| Price | $26.29 | $19.38 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 7 | 8 |
| Target Price | ★ $32.86 | $27.50 |
| AVG Volume (30 Days) | 885.6K | ★ 1.2M |
| Earning Date | 02-26-2026 | 01-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.47 | 0.22 |
| Revenue | $716,791,000.00 | ★ $1,370,763,000.00 |
| Revenue This Year | $6.24 | $8.56 |
| Revenue Next Year | $9.53 | $15.95 |
| P/E Ratio | ★ $55.17 | $84.50 |
| Revenue Growth | 3.14 | ★ 10.76 |
| 52 Week Low | $18.18 | $14.20 |
| 52 Week High | $27.64 | $29.80 |
Technical Indicators
Market Signals| Indicator | PCRX | PENG |
|---|---|---|
| Relative Strength Index (RSI) | 56.92 | 44.15 |
| Support Level | $24.20 | $18.12 |
| Resistance Level | $26.48 | $23.99 |
| Average True Range (ATR) | 0.98 | 0.98 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 68.46 | 20.23 |
Price Performance
Historical ComparisonAbout PCRX Pacira BioSciences Inc.
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
About PENG Penguin Solutions Inc. Ordinary Shares
Penguin Solutions Inc is an end-to-end technology company engaged in Intelligent Platform Solutions, Integrated Memory, and Optimized LED business. Its product include Servers, software, OCP HPC & AI system, Racks and Edge. Servers include AMD-based Serves, Intel-based Servers, etc. Software products include Scyld ClusterWare, Scyld Cloud Central, etc. OCP HPC & AI Systems includes OCP Servers & Storage and etc.